KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Charles River Laboratories International (CRL) Current Leases (2018)

Charles River Laboratories International has reported Current Leases over the past 1 years, most recently at $3.2 million for Q4 2018.

For Q4 2018, Current Leases changed N/A year-over-year to $3.2 million; the TTM value through Dec 2018 reached $3.2 million, changed N/A, while the annual FY2018 figure was $3.2 million, N/A changed from the prior year.
Current Leases for Q4 2018 was $3.2 million at Charles River Laboratories International.
Over five years, Current Leases peaked at $3.2 million in Q4 2018 and troughed at $3.2 million in Q4 2018.